1 Result(s)

Article

Low number of intrafollicular T cells may predict favourable response to rituximab-based immuno-chemotherapy in advanced follicular lymphoma: a secondary analysis of a randomized clinical trial

First-line rituximab therapy together with chemotherapy is the standard care for patients with advanced follicular B-cell lymphoma, as rituximab together with chemotherapy prolongs progression-free and overall...

Laura Budau, Christian Wilhelm, Roland Moll… in Journal of Cancer Research and Clinical On… (2019)